Antiretroviral therapy: effects on orofacial health and health care
Authors:
- 27 March 2013
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 20 (2) , 136-145
Abstract
This study summarizes the adverse effects of antiretroviral therapy (ART) agents against HIV on orofacial health and health care. Current antiretroviral agents fall mainly into three major classes: nucleoside reverse‐transcriptase inhibitors (NRTIs), non‐nucleoside reverse‐transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) – now with the new classes of fusion inhibitors, entry inhibitors ‐CCR5 co‐receptor antagonists and HIV integrase strand transfer inhibitors. Many of the ART agents can have adverse orofacial effects, or can give rise to allergies or drug interactions – the optimum anti‐HIV drug has yet to be found. There are few orofacial adverse effects that characterize a particular ART class, but erythema multiforme (EM), ulcers and xerostomia may be associated with reverse‐transcriptase inhibitors (RTI); parotid lipomatosis, taste disturbance, xerostomia and perioral paraesthesia mainly related to PIs. Facial lipoatrophy is a common adverse effect of NRTIs; EM is more frequently associated with NNRTIs. Thus, although most of the more recent ART drugs and combinations of them show improved safety profiles, some may give rise to orofacial adverse effects, and may affect oral health care.Keywords
This publication has 46 references indexed in Scilit:
- Surgical management of bilateral parotid lipomatosis in a patient with HIVHead & Neck, 2012
- Antiretroviral Prophylaxis and the Risk of Cleft Lip and Palate: Preliminary Signal Detection in the Food and Drug Administration's Adverse Events Reporting System DatabaseThe Cleft Palate Craniofacial Journal, 2012
- Individualization of antiretroviral therapyPharmacogenomics and Personalized Medicine, 2011
- Cutaneous toxicities of antiretroviral therapy for HIVJournal of the American Academy of Dermatology, 2010
- Cutaneous toxicities of antiretroviral therapy for HIVJournal of the American Academy of Dermatology, 2010
- Effects of long‐term use of HAART on oral health status of HIV‐infected subjectsJournal of Oral Pathology & Medicine, 2010
- The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical ImplicationsToxicologic Pathology, 2009
- Effect of HAART on salivary gland function in the Women’s Interagency HIV Study (WIHS)Oral Diseases, 2008
- Cheilitis in association with indinavirSexually Transmitted Infections, 2000
- Management of the Adverse Effects of Antiretroviral Therapy and Medication AdherenceClinical Infectious Diseases, 2000